As of 2026-09-24, the Relative Valuation of ACADIA Pharmaceuticals Inc (ACAD) is 43.39 USD. This relative valuation is based on P/E multiples. With the latest stock price at 22.18 USD, the upside of ACADIA Pharmaceuticals Inc based on Relative Valuation is 95.6%.
The range of the Relative Valuation is 19.64 - 67.77 USD.
| Range | Selected | |
| Trailing P/E multiples | 26.1x - 30.5x | 30.1x |
| Forward P/E multiples | 24.9x - 27.5x | 25.2x |
| Fair Price | 19.64 - 67.77 | 43.39 |
| Upside | -11.4% - 205.5% | 95.6% |
| Date | P/E |
| 2026-09-23 | 11.44 |
| 2026-09-22 | 11.89 |
| 2026-09-21 | 11.88 |
| 2026-09-18 | 12.28 |
| 2026-09-17 | 12.35 |
| 2026-09-16 | 12.39 |
| 2026-09-15 | 12.04 |
| 2026-09-14 | 12.39 |
| 2026-09-11 | 12.53 |
| 2026-09-10 | 12.48 |
| 2026-09-09 | 12.46 |
| 2026-09-08 | 12.41 |
| 2026-09-04 | 12.61 |
| 2026-09-03 | 12.54 |
| 2026-09-02 | 13.02 |
| 2026-09-01 | 13.00 |
| 2026-08-31 | 13.01 |
| 2026-08-28 | 13.10 |
| 2026-08-27 | 13.38 |
| 2026-08-26 | 13.31 |
| 2026-08-25 | 13.76 |
| 2026-08-24 | 13.34 |
| 2026-08-21 | 13.28 |
| 2026-08-20 | 13.07 |
| 2026-08-19 | 13.60 |
| 2026-08-18 | 13.58 |
| 2026-08-17 | 13.06 |
| 2026-08-14 | 12.71 |
| 2026-08-13 | 12.77 |
| 2026-08-12 | 13.25 |
| 2026-08-11 | 13.24 |
| 2026-08-10 | 13.23 |
| 2026-08-07 | 13.15 |
| 2026-08-06 | 12.80 |
| 2026-08-05 | 12.96 |
| 2026-08-04 | 12.22 |
| 2026-08-03 | 11.53 |
| 2026-07-31 | 11.64 |
| 2026-07-30 | 11.95 |
| 2026-07-29 | 11.85 |
| 2026-07-28 | 11.71 |
| 2026-07-27 | 11.43 |
| 2026-07-24 | 11.18 |
| 2026-07-23 | 11.17 |
| 2026-07-22 | 11.23 |
| 2026-07-21 | 11.44 |
| 2026-07-20 | 11.29 |
| 2026-07-17 | 11.52 |
| 2026-07-16 | 11.53 |
| 2026-07-15 | 11.67 |